What to try while congestive heart failure patients are still ambulatory

S H Jennison1, L W Miller

  • 1Division of Cardiology, St Louis University School of Medicine, MO 63110.

Postgraduate Medicine
|October 1, 1993
PubMed

Insights

Angiotensin-converting enzyme (ACE) inhibitors significantly improve survival in congestive heart failure (CHF) patients across various New York Heart Association classes. ACE inhibitors also reduce cardiovascular events in post-myocardial infarction patients with left ventricular dysfunction.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • The traditional stepped-care approach for congestive heart failure (CHF) is outdated.
  • Improved understanding of CHF pathophysiology necessitates revised treatment strategies.

Purpose of the Study:

  • To evaluate the efficacy of angiotensin-converting enzyme (ACE) inhibitors in improving survival and reducing cardiovascular events in CHF patients.
  • To assess the role of ACE inhibitors in post-myocardial infarction patients with left ventricular dysfunction.

Main Methods:

  • Review of evidence supporting the use of vasodilators, specifically ACE inhibitors, in CHF management.
  • Analysis of studies on long-term captopril administration in post-myocardial infarction patients.

Main Results:

  • ACE inhibitors improve survival in New York Heart Association classes II-IV CHF compared to placebo or direct-acting vasodilators.
  • Long-term captopril use enhances survival and reduces morbidity/mortality from cardiovascular events in asymptomatic post-MI patients with left ventricular dysfunction.
  • Preventive therapy with ACE inhibitors should be considered for post-MI patients with asymptomatic left ventricular dysfunction (ejection fraction ≤40%).

Conclusions:

  • ACE inhibitors are the preferred vasodilators for improving survival in congestive heart failure.
  • Early intervention with ACE inhibitors in post-myocardial infarction patients with left ventricular dysfunction is recommended.
  • Further research is needed to define the role of newer vasodilators and beta-blockers in CHF management.

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...